Clinical Trials Directory

Trials / Unknown

UnknownNCT01468116

The Effect of Roux-en-Y Gastric Bypass on Mitochondrial Function in Type 2 Diabetes

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Roux-en-Y gastric bypass (RYGB) surgery induces resolution of type 2 diabetes, often within days after surgery and before significant weight loss. The aim of this study is to investigate whether changes in mitochondrial function contributes to the early improvement of type 2 diabetes after RYGB.

Detailed description

Mitochondrial dysfunction has been linked to development of insulin resistance in the muscle and hence to the pathogenesis of type 2 diabetes. Mitochondrial function can be studied non-invasively by 31 Phosphor Magnetic Resonance spectroscopy (31PMRS). In this study we will investigate changes in mitochondrial function using the combination of 31 PMRS and Near Infra-Red Spectroscopy (NIRS) after gastric bypass.

Conditions

Timeline

Start date
2011-03-01
Primary completion
2013-06-01
Completion
2013-12-01
First posted
2011-11-09
Last updated
2011-11-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01468116. Inclusion in this directory is not an endorsement.